TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression

BACKGROUND: Breast cancer is the most common cancer in women worldwide. More than 70% of breast cancers are estrogen receptor (ER) alpha positive. Compared with ER alpha-negative breast cancer, which is more aggressive and has a shorter survival time, ER alpha-positive breast cancer could benefit fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Ting, Wang, Beibei, Tan, Xiaojing, Wu, Le, Li, Xin, Li, Zhongbo, Cai, Yuqing, Fan, Rongrong, Yang, Xiao, Zhang, Chenmiao, Xia, Yan, Niu, Zhiguo, Liu, Bingtian, Cao, Qi, Ding, Yinlu, Zhou, Zhipeng, Huang, Qingsong, Yang, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991925/
https://www.ncbi.nlm.nih.gov/pubmed/35392925
http://dx.doi.org/10.1186/s12964-022-00861-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991925/
https://www.ncbi.nlm.nih.gov/pubmed/35392925
http://dx.doi.org/10.1186/s12964-022-00861-z

Ejemplares similares